Stroke care in Italy at the time of the COVID-19 pandemic: a lesson to learn.
Care
Covid-19
Emergency
Italy
Outbreak
Pathways
Stroke
Journal
Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
17
06
2020
accepted:
29
08
2020
revised:
27
08
2020
pubmed:
22
9
2020
medline:
24
6
2021
entrez:
21
9
2020
Statut:
ppublish
Résumé
From March to May 2020, the Italian health care system, as many others, was almost entirely devoted to the fight against the COVID-19 pandemic. In this context, a number of questions arose, from the increased stroke risk due to COVID-19 infection to the quality of stroke patient care. The overwhelming need of COVID-19 patient management made mandatory a complete re-organization of the stroke pathways: many health professionals were reallocated and a number of stroke units was turned into COVID-19 wards. As a result, acute stroke care suffered from a shortage of services and delays in time-dependent treatments and diagnostic work-up. In-patient and out-patient care and rehabilitation facilities for stroke survivors were also reduced or slowed down, to direct resources to COVID-19 patients care and to reduce contagion risks. Overall, this is likely to result in a significant future increased burden of complications and disabilities that will impact the health care systems in the coming months. Thus, while still fighting against COVID-19 disease, authorities need to promptly implement robust action plans, including an increase of workforce, without forgetting the assurance of a high level of stroke care. The medical community and the health care administrators should always keep in mind that stroke was before, and will be after the pandemic, a, sometimes, life-threatening condition, and almost always a disease with a severe impact on the quality of life.
Identifiants
pubmed: 32954445
doi: 10.1007/s00415-020-10200-2
pii: 10.1007/s00415-020-10200-2
pmc: PMC7502274
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2307-2313Références
COVID-19 information and resources for JHU in https://hub.jhu.edu/novel-coronavirus-information . Accessed 27 August 2020
Remuzzi A, Remuzzi G (2020) COVID-19 and Italy: what next? Lancet 395:1225–1228
pubmed: 32178769
pmcid: 7102589
Rosenbaum L (2020) Facing Covid-19 in Italy—ethics, logistics, and therapeutics on the epidemic’s front line. N Engl J Med 382:1873–1875
pubmed: 32187459
Bersano A, Pantoni L (2020) On being a neurologist in Italy at the time of the COVID-19 outbreak. Neurology 94:905–906
pubmed: 32245844
Spina S, Marrazzo F, Migliari M, Stucchi R, Sforza A, Fumagalli R (2020) The response of Milan’s Emergency Medical System to the COVID-19 outbreak in Italy. Lancet 395:e49–e50
pubmed: 32119824
pmcid: 7124430
Kohli P, Virani SS (2020) Surfing the waves of the COVID-19 pandemic as a cardiovascular clinician. Circulation. https://doi.org/10.1161/circulationaha.120.047901
doi: 10.1161/circulationaha.120.047901
pubmed: 32369419
Dafer RM, Osteraas ND, Biller J (2020) Acute stroke care in the coronavirus disease 2019 pandemic. J Stroke Cerebrovasc Dis 29:104881
pubmed: 32334918
pmcid: 7164903
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054–1062
pubmed: 32171076
pmcid: 32171076
Aggarwal G, Lippi G, Michael Henry B (2020) Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): a pooled analysis of published literature. Int J Stroke 15:385–389
pubmed: 32310015
Hui DS, Chan PK (2010) Severe acute respiratory syndrome and coronavirus. Infect Di Clin North Am 24:619–638
Yashavantha Rao HC, Jayabaskaran C (2020) The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients. J Med Virol 92:786–790
pubmed: 32320066
Asadi-Pooya AA, Simani L (2020) Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci 413:116832
pubmed: 32299017
pmcid: 7151535
Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S (2020) Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2020.2065
doi: 10.1001/jamaneurol.2020.2065
pubmed: 32469387
pmcid: 7484225
Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K (2020) Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clin Neurol Neurosurg 194:105921
pubmed: 32422545
pmcid: 7227498
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 77:1–9
pmcid: 7149362
Zhou Z, Kang H, Li S, Zhao X (2020) Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. https://doi.org/10.1007/s00415-020-09929-7
doi: 10.1007/s00415-020-09929-7
pubmed: 32860084
pmcid: 7249973
Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, Humphries F, Jäger HR, Losseff NA, Perry RJ, Shah S, Simister RJ, Turner D, Chandratheva A, Werring DJ (2020) Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. https://doi.org/10.1136/jnnp-2020-323586
doi: 10.1136/jnnp-2020-323586
pubmed: 32354768
Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, Henninger N, Trivedi T, Lillemoe K, Alam S, Sanger M, Kim S, Scher E, Dehkharghani S, Wachs M, Tanweer O, Volpicelli F, Bosworth B, Lord A, Frontera J (2020) SARS-CoV-2 and stroke in a New York healthcare system. Stroke 51:2002–2011
pubmed: 32432996
Tsivgoulis G, Katsanos AH, Ornello R, Sacco S (2020) Ischemic stroke epidemiology during the COVID-19 pandemic: navigating uncharted waters with changing tides. Stroke 51:1924–1926
pubmed: 32496937
Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, Merdji H, Clere-Jehl R, Schenck M, Fagot Gandet F, Fafi-Kremer S, Castelain V, Schneider F, Grunebaum L, Anglés-Cano E, Sattler L, Mertes PM, Meziani F (2020) High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 46:1089–1098
Benussi A, Pilotto A, Premi E, Libri I, Giunta M, Agosti C, Alberici A, Baldelli E, Benini M, Bonacina S, Brambilla L, Caratozzolo S, Cortinovis M, Costa A, Piccinelli SC, Cottini E, Cristillo V, Delrio I, Filosto M, Gamba M, Gazzina S, Gilberti N, Gipponi S, Imarisio A, Invernizzi P, Leggio U, Leonardi M, Liberini P, Locatelli M, Masciocchi S, Poli L, Rao R, Risi B, Rozzini L, Scalvini A, Schiano di Cola F, Spezi R, Vergani V, Volonghi I, Zoppi N, Borroni B, Magoni M, Pezzini A, Padovani A (2020) Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy. Neurology. https://doi.org/10.1212/WNL.0000000000009848
doi: 10.1212/WNL.0000000000009848
pubmed: 32943482
pmcid: 7836664
Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18:844–847
pubmed: 32073213
pmcid: 7166509
Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, Jain SS, Burkhoff D, Kumaraiah D, Rabbani L, Schwartz A, Uriel N (2020) Coronavirus Disease 2019 (COVID-19) and cardiovascular disease. Circulation 141:1648–1655
pubmed: 32200663
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z (2020) Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 27:e201017. https://doi.org/10.1001/jamacardio.2020.1017
doi: 10.1001/jamacardio.2020.1017
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C, Pöhlmann S (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271–280
pubmed: 32142651
pmcid: 32142651
Kuster GM, Osswald S (2020) Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence. Eur Heart J 41:1857
pubmed: 32324223
Kuster GM, Pfister O, Burkard T, Zhou Q, Twerenbold R, Haaf P, Widmer AF, Osswald S (2020) SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur Heart J 41:1801–1803
pubmed: 32196087
pmcid: 7184407
Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD (2020) Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med 382:1653–1659
Stefanini GG, Azzolini E, Condorelli G (2020) Critical organizational issues for cardiologists in the covid-19 outbreak: a frontline experience from Milan, Italy. Circulation 141:1597–1599
pubmed: 32207994
Grasselli G, Pesenti A, Cecconi M (2020) Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA. https://doi.org/10.1001/jama.2020.4031
doi: 10.1001/jama.2020.4031
pubmed: 32250385
pmcid: 7136855
https://www.regione.lombardia.it/wps/wcm/connect/5e0deec4-caca-409c-825b-25f781d8756c/DGR+2906+8+marzo+2020.pdf?MOD=AJPERES&CACHEID=ROOTWORKSPACE-5e0deec4-caca-409c-825b-25f781d8756c-n2.vCsc . Accessed 27 August 2020
Meschi T, Rossi S, Volpi A, Ferrari C, Sverzellati N, Brianti E, Fabi M, Nouvenne A, Ticinesi A (2020) Reorganization of a large academic hospital to face COVID-19 outbreak: the model of Parma, Emilia-Romagna region, Italy. Eur J Clin Invest 50:e13250
pubmed: 32367527
pmcid: 7262013
Baracchini C, Pieroni A, Viaro F, Cianci V, Cattelan AM, Tiberio I, Munari M, Causin F (2020) Acute stroke management pathway during Coronavirus-19 pandemic. Neurol Sci 41:1003–1005
pubmed: 32270359
Caso V, Federico A (2020) No lockdown for neurological diseases during COVID19 pandemic infection. Neurol Sci 41:999–1001
pubmed: 32270358
Morelli N, Rota E, Terracciano C, Immovilli P, Spallazzi M, Colombi D, Zaino D, Taga A, Michieletti E, Guidetti D (2020) The baffling case of ischemic stroke disappearance from the Casualty Department in the COVID-19 Era. Eur Neurol. https://doi.org/10.1159/000509002
doi: 10.1159/000509002
pubmed: 32526743
Markus HS, Brainin M (2020) EXPRESS: COVID-19 and Stroke—a global world stroke organisation perspective. Int J Stroke 15:361–364
pubmed: 32310017
WSO; Stroke Care and the COVID19 Pandemic Words from our President. https://www.world-stroke.org/news-and-blog/news/stroke-care-and-the-covid19 - pandemic. Accessed 27 August 2020
Montaner J, Barragán-Prieto A, Pérez-Sánchez S, Escudero-Martínez I, Moniche F, Sánchez-Miura JA, Ruiz-Bayo L, González A (2020) Break in the stroke chain of survival due to COVID-19. Stroke. https://doi.org/10.1161/strokeaha.120.030106
doi: 10.1161/strokeaha.120.030106
pubmed: 33317415
pmcid: 7282408
Avula A, Nalleballe K, Narula N, Sapozhnikov S, Dandu V, Toom S, Glaser A, Elsayegh D (2020) COVID-19 presenting as stroke. Brain Behav Immun. https://doi.org/10.1016/j.bbi.2020.04.077
doi: 10.1016/j.bbi.2020.04.077
pubmed: 32561222
pmcid: 7297688
Gori T, Lelieveld J, Münzel T (2020) Perspective: cardiovascular disease and the Covid-19 pandemic. Basic Res Cardiol 115:32
pubmed: 32277299
pmcid: 7146013
Rothan HA, Byrareddy SN (2020) The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 109:102433
pubmed: 32113704
pmcid: 7127067
Zhao J, Rudd A, Liu R (2020) Challenges and potential solutions of stroke care during the coronavirus disease 2019 (COVID-19) outbreak. Stroke 51:1356–1357
pubmed: 32228369
pmcid: 7219852
Lancet The (2020) COVID-19: protecting health-care workers. Lancet 395:922
https://apps.who.int/iris/bitstream/handle/10665/331509/WHO-COVID-19-lab_testing-2020.1-eng.pdf . Accessed 27 August 2020
Ahmed F, Ahmed N, Pissarides C, Stiglitz J (2020) Why inequality could spread COVID-19. Lancet Public Health 5:e240
pubmed: 32247329
pmcid: 7270465
Marshall IJ, Wang Y, Crichton S, McKevitt C, Rudd AG, Wolfe CD (2015) The effects of socioeconomic status on stroke risk and outcomes. Lancet Neurol 14:1206–1218
pubmed: 26581971
Ferrario MM, Veronesi G, Kee F, Chambless LE, Kuulasmaa K, Jørgensen T, Amouyel P, Arveiler D, Bobak M, Cesana G, Drygas W, Ferrieres J, Giampaoli S, Iacoviello L, Nikitin Y, Pajak A, Peters A, Salomaa V, Soderberg S, Tamosiunas A, Wilsgaard T, Tunstall-Pedoe H, MORGAM Project (2017) Determinants of social inequalities in stroke incidence across Europe: a collaborative analysis of 126,635 individuals from 48 cohort studies. J Epidemiol Community Health 71:1210–1216
pubmed: 28983063
Yancy CW (2020) COVID-19 and African Americans. JAMA. https://doi.org/10.1001/jama.2020.6548
doi: 10.1001/jama.2020.6548
pubmed: 33211084
pmcid: 7718608
Zaka A, Shamloo SE, Fiorente P, Tafuri A (2020) COVID-19 pandemic as a watershed moment: a call for systematic psychological health care for frontline medical staff. J Health Psychol 25:883–887
pubmed: 32370621
Pfefferbaum B, North CS (2020) Mental health and the Covid-19 Pandemic. N Engl J Med. https://doi.org/10.1056/nejmp2008017
doi: 10.1056/nejmp2008017
pubmed: 32283003
Choo EK, Rajkumar SV (2020) Medication shortages during the COVID-19 crisis: what we must do. Mayo Clin Proc 95:1112–1115
pubmed: 32312491
Hill JA, McGuire DK, de Lemos JA (2020) Science in a time of crisis. Circulation 141:1277–1278
pubmed: 32200665
pmcid: 7172554
http://www.salute.gov.it/imgs/C_17_bandi_216_0_file.pdf . Accessed 27 Aug 2020
https://www.ean.org/congress-2020 . Accessed 27 Aug 2020
Agarwal S, Sabadia S, Abou-Fayssal N, Kurzweil A, Balcer LJ, Galetta SL (2020) Training in neurology: flexibility and adaptability of a neurology training program at the epicenter of COVID-19. Neurology 94:e2608–e2614
pubmed: 32385187
Aguiar de Sousa D, Sandset EC, Elkind MSV (2020) The curious case of the missing strokes during the COVID-19 pandemic. Stroke. https://doi.org/10.1161/strokeaha.120.030792
doi: 10.1161/strokeaha.120.030792
pubmed: 33297867
pmcid: 7282410
Schirmer CM, Ringer AJ, Arthur AS, Binning MJ, Fox WC, James RF, Levitt MR, Tawk RG, Veznedaroglu E, Walker M, Spiotta AM, Endovascular Research Group (ENRG) (2020) Delayed presentation of acute ischemic strokes during the COVID-19 crisis. J Neurointerv Surg 12:639–642
pubmed: 32467244
Bersano A, Kraemer M, Touzé E, Weber R, Alamowitch S, Sibon I, Pantoni L (2020) Stroke care during the Covid-19 pandemic: experience from three large European countries. Eur J Neurol. https://doi.org/10.1111/ene.14375
doi: 10.1111/ene.14375
pubmed: 32526074
pmcid: 7307116
Boldrini P, Garcea M, Brichetto G, Reale N, Tonolo S, Falabella V, Fedeli F, Cnops AA, Kiekens C (2020) Living with a disability during the pandemic. “Instant paper from the field” on rehabilitation answers to the COVID-19 emergency. Eur J Phys Rehabil Med. https://doi.org/10.23736/s1973-9087.20.06373-x
doi: 10.23736/s1973-9087.20.06373-x
pubmed: 32406226
Greenhalgh T, Wherton J, Shaw S, Morrison C (2020) Video consultations for covid-19. BMJ 368:998. https://doi.org/10.1136/bmj.m998
doi: 10.1136/bmj.m998
Hollander JE, Carr BG (2020) Virtually perfect? telemedicine for Covid-19. N Engl J Med 382:1679–1680
pubmed: 32160451
Khosravani H, Rajendram P, Notario L, Chapman M, Menon BK (2020) protected code stroke. hyperacute stroke management during the coronavirus disease 2019 (COVID-19) pandemic. Stroke 51:1891
pubmed: 32233980
pmcid: 7258750
Leira EC, Russman AN, Biller J, Brown DL, Bushnell CD, Caso V, Chamorro A, Creutzfeldt CJ, Cruz-Flores S, Elkind MSV, Fayad P, Froehler MT, Goldstein LB, Gonzales NR, Kaskie B, Khatri P, Livesay S, Liebeskind DS, Majersik JJ, Moheet AM, Romano JG, Sanossian N, Sansing LH, Silver B, Simpkins AN, Smith W, Tirschwell DL, Wang DZ, Yavagal DR, Worrall BB (2020) Preserving stroke care during the COVID-19 pandemic: potential issues and solutions. Neurology 95(3):124–133
pubmed: 32385186
Liu R, Zhao J, Fisher M (2020) The global impact of COVID-19 on acute stroke care. CNS Neurosci Ther. https://doi.org/10.1111/cns.13442
doi: 10.1111/cns.13442
pubmed: 33369110
pmcid: 7816202